Alyeska Investment Group
BIOA

Alyeska Investment Group’s BioAge Labs BIOA Stock Holding History

Alyeska Investment Group’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-75,000
Closed -$1.31M – 818
2026
Q1 		$1.31M Buy
+75,000
New +$1.44M ﹤0.01% 565
2024
Q4 		– Sell
-150,000
Closed -$3.12M – 684
2024
Q3 		$3.12M Buy
+150,000
New +$3.01M 0.02% 387

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Alyeska Investment Group's BIOA Position: Q2 2026 in Review

Alyeska Investment Group sold out of BioAge Labs (BIOA) in Q2 2026, closing a stake of 75,000 shares — an estimated $1.31M sold.

Alyeska Investment Group first reported a position in BIOA in Q3 2024 and held it in 2 quarters. The position peaked at $3.12M in Q3 2024. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Alyeska Investment Group reported no remaining BioAge Labs position as of Q2 2026 after selling out during the quarter.
  • Alyeska Investment Group sold 75,000 BioAge Labs shares in Q2 2026, an estimated $1.31M.
  • Alyeska Investment Group first reported a position in BioAge Labs in Q3 2024 and held it in 2 quarters.
  • Alyeska Investment Group's BioAge Labs position peaked at $3.12M in Q3 2024.
  • 151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.